10-20046930-G-A

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_032812.9(PLXDC2):​c.386G>A​(p.Arg129Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000285 in 1,612,326 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000039 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000027 ( 0 hom. )

Consequence

PLXDC2
NM_032812.9 missense

Scores

1
5
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 5.25

Publications

2 publications found
Variant links:
Genes affected
PLXDC2 (HGNC:21013): (plexin domain containing 2) Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0883117).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PLXDC2NM_032812.9 linkc.386G>A p.Arg129Gln missense_variant Exon 3 of 14 ENST00000377252.5 NP_116201.7 Q6UX71-1
PLXDC2XM_011519750.3 linkc.386G>A p.Arg129Gln missense_variant Exon 3 of 14 XP_011518052.1
PLXDC2NM_001282736.2 linkc.325-21240G>A intron_variant Intron 2 of 12 NP_001269665.1 Q6UX71-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PLXDC2ENST00000377252.5 linkc.386G>A p.Arg129Gln missense_variant Exon 3 of 14 1 NM_032812.9 ENSP00000366460.3 Q6UX71-1
PLXDC2ENST00000377242.7 linkc.325-21240G>A intron_variant Intron 2 of 12 1 ENSP00000366450.3 Q6UX71-2
PLXDC2ENST00000377238.2 linkn.161G>A non_coding_transcript_exon_variant Exon 2 of 13 5

Frequencies

GnomAD3 genomes
AF:
0.0000395
AC:
6
AN:
151878
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000242
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000577
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000519
AC:
13
AN:
250450
AF XY:
0.0000295
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000708
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000274
AC:
40
AN:
1460328
Hom.:
0
Cov.:
30
AF XY:
0.0000234
AC XY:
17
AN XY:
726556
show subpopulations
African (AFR)
AF:
0.0000898
AC:
3
AN:
33408
American (AMR)
AF:
0.00
AC:
0
AN:
44512
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26086
East Asian (EAS)
AF:
0.000328
AC:
13
AN:
39586
South Asian (SAS)
AF:
0.0000464
AC:
4
AN:
86150
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53364
Middle Eastern (MID)
AF:
0.000174
AC:
1
AN:
5752
European-Non Finnish (NFE)
AF:
0.0000117
AC:
13
AN:
1111164
Other (OTH)
AF:
0.0000995
AC:
6
AN:
60306
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000395
AC:
6
AN:
151998
Hom.:
0
Cov.:
32
AF XY:
0.0000404
AC XY:
3
AN XY:
74268
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41472
American (AMR)
AF:
0.00
AC:
0
AN:
15224
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.000579
AC:
3
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4814
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10560
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
67964
Other (OTH)
AF:
0.00
AC:
0
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000117
Hom.:
0
Bravo
AF:
0.0000378
ExAC
AF:
0.0000494
AC:
6

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Sep 14, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.386G>A (p.R129Q) alteration is located in exon 3 (coding exon 3) of the PLXDC2 gene. This alteration results from a G to A substitution at nucleotide position 386, causing the arginine (R) at amino acid position 129 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.078
BayesDel_addAF
Benign
-0.24
T
BayesDel_noAF
Benign
-0.21
CADD
Uncertain
24
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.020
T
Eigen
Uncertain
0.42
Eigen_PC
Uncertain
0.50
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Benign
0.85
T
M_CAP
Benign
0.046
D
MetaRNN
Benign
0.088
T
MetaSVM
Benign
-0.42
T
MutationAssessor
Benign
1.3
L
PhyloP100
5.3
PrimateAI
Uncertain
0.61
T
PROVEAN
Benign
-1.4
N
REVEL
Uncertain
0.32
Sift
Benign
0.21
T
Sift4G
Benign
0.24
T
Polyphen
0.98
D
Vest4
0.40
MVP
0.24
MPC
0.43
ClinPred
0.26
T
GERP RS
5.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.19
gMVP
0.41
Mutation Taster
=72/28
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs540394643; hg19: chr10-20335859; COSMIC: COSV65909263; API